lauralea

Bottom Fishing

NASDAQ:HOLX   Hologic, Inc
Yearly low is 49.19. Yearly high is 85. Bearish divergence at top, and it is an ugly top! HOLX also fell from a series of bearish rising wedges that I did not draw as at this point they are not as significant.

Struggling to say the least and the moving averages are screwed up and out of place. Only the 200 is still sloping up which is the longest term moving average I use. The 50 just crossed down and through the 200 which some refer to as a death cross.

Large Volume noted in the past week or so of trading.

This plateau may not be for real but price has formed a horizontal trading zone and a stop around 61 would put you below the prior low It looks like the first drop down was followed by a brief rise up which was most likely a bear flag . Bear flags/ pennants can mark the half way pint in a fall, but not always.
There is a pocket pivot below price. I like pocket pivots (o:

This has pulled back very close to the 1.13 but is definitely still in the woods for now.

This can drop suddenly, especially when it is nearing the top. I guess any stock can though. I trade this one over and over because I am familiar with how it moves. Sometimes picking a basket of stocks and trading them over and over can be beneficial because you can begin to know how they move.

No recommendation.

Hologic , Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet , Inc. to advance the use of artificial intelligence in breast health. Hologic , Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

EPS ( FWD )
7.62
PE ( FWD )
8.23